Site Map Press Room Careers
Financial
Quarterly Results
Financial Highlights
Annual Reports
Business Drivers
Investors
Contact Person
Frequently Asked Questions

Unaudited Quarterly Results for the 3rd quarter & period ended 31st December, 2005

(Rs. in Mio)

  Three Months Ended Nine Months Ended Year ended

Particulars

(Unaudited) (Unaudited) (Audited)
  31.12.2005 31.12.2004 31.12.2005 31.12.2004 31.03.2005
Net Sales/Income from Operations 4090.2 3193.3 10091.6 8735.7 11591.7
Other Income 79.5 40.1 191.5 90.4 165.6
Total Income 4169.7 3233.4 10283.1 8826.1 11757.3
Expenditure          
a. (Increase) / Decrease in Stock in Trade
10.9 55.5 (128.2) (128.1) (132.4)
 b. Consumption of Raw Materials 2409.2 1717.2 6241.0 4851.5 6574.4
 c. Staff Cost 220.0 194.4 589.7 525.6 662.3
 d. Other Expenditure 868.1 904.9 2361.8 2521.7 3419.1
Total expenditure 3508.2 2872.0 9064.3 7770.7 10523.4
Profit Before Depreciation, Interest & Tax 661.5 361.4 1218.8 1055.4 1233.9
Interest 162.9 104.2 438.6 279.6 399.9
Depreciation 134.6 125.8 377.8 358.0 404.9
Profit before taxation 364.0 131.4 402.4 417.8 429.8
Provision for Taxation
a) Current Tax
b) Deferred Tax
c. Fringe Benefit Tax
d) Tax adjustments of previous years
31.2
70.2
0.7
0
9.5
23.4
--
(7.4)
36.1
45.9
1.9
0.1
34.7
69.6
--
--
40.1
38.8
--
(0.5)
Net Profit 261.9 105.9 318.4 311.7 350.7
Paid-up Equity Share Capital 
(Face value Rs. 5/- per share)
2663.5 2538.5 2663.5 2538.5 2538.5
Reserves excluding Revaluation Reserves -- -- -- -- 7632.0
Earnings per share (Rs.) (not annualised)          
- Basic
4.92 2.09 6.10 6.14 6.91
-Diluted
4.49 2.09 5.81 6.14 6.91
Aggregate of non-promoters Shareholding          
a. Number of Shares     23549057 22939656 22939156
b. Percentage of Shareholding     44.21 45.18  45.18
 
Notes:
1. The above unaudited results which are subjected to limited review by the Auditors of the Company, were reviewed by the Audit Committee and have been taken on record by the Board at its meeting held on 31.01.2006.
2 Exports constitute Rs.2338.0 millions (Rs.1522.9 millions) of the sales for the quarter.
3. The Company's operations fall within a single primary business segment viz 'Pharmaceutical Products'.
4. Investor  complaints  pending  at  the  beginning  of  the  quarter: Nil,  received: 104,  resolved: 104 and lying unresolved at the end of the quarter: Nil. 
5. Figures for the previous periods have been rearranged/regrouped wherever necessary.
For and on behalf of the Board
Sd/-
Place: Hyderabad K.Nityananda Reddy
Date : 31.01.2006 Managing Director
Site Map Press Room Careers